Dongyang Liu
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Oncology 39
- Drug Transport and Resistance Mechanisms 16
- Co-authors
- Xueting Yao (34 shared papers)Haiyan Li (26 shared papers)Cheng Cui (24 shared papers)Chunli Song (9 shared papers)Miao Zhang (6 shared papers)Erdan Dong (1 shared paper)Fei Ye (1 shared paper)Xu Liu (1 shared paper)
- Journals
- Frontiers in Pharmacology (9 papers)European Journal of Pharmaceutical Sciences (9 papers)Clinical Pharmacokinetics (8 papers)Clinical Pharmacology & Therapeutics (5 papers)Journal of Chromatography B (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Dongyang Liu
165 papers receiving 3.8k citations
Dongyang Liu's Hit Papers
Peers
Comparison fields: 5 of 175
- Infectious Diseases 1.5k
- Pharmacology 322
- Neurology 555
- Ophthalmology 177
- Analytical Chemistry 177
Countries citing papers authored by Dongyang Liu
This map shows the geographic impact of Dongyang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyang Liu more than expected).
Fields of papers citing papers by Dongyang Liu
This network shows the impact of papers produced by Dongyang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyang Liu. The network helps show where Dongyang Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongyang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hit paper breakdown → | 2020 | 1855 |
| 2 | 2019 | 229 | |
| 3 | 2017 | 118 | |
| 4 | 2021 | 100 | |
| 5 | 2010 | 81 | |
| 6 | 2007 | 65 | |
| 7 | 2008 | 49 | |
| 8 | 2020 | 44 | |
| 9 | 2010 | 40 | |
| 10 | 2014 | 37 | |
| 11 | 2019 | 34 | |
| 12 | 2021 | 34 | |
| 13 | 2011 | 33 | |
| 14 | 2021 | 33 | |
| 15 | 2020 | 30 | |
| 16 | 2009 | 30 | |
| 17 | 2020 | 27 | |
| 18 | 2018 | 26 | |
| 19 | 2021 | 26 | |
| 20 | 2008 | 25 |
About Dongyang Liu
Dongyang Liu is a scholar working on Oncology, Molecular Biology, Pharmacology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 183 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (18 papers), Diabetes Treatment and Management (16 papers), Drug Transport and Resistance Mechanisms (16 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Analytical Methods in Pharmaceuticals (10 papers), Pancreatic function and diabetes (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Zeolite Catalysis and Synthesis (8 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Pharmacology (322 citations), Neurology (555 citations), Ophthalmology (177 citations) and Analytical Chemistry (177 citations). Dongyang Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xueting Yao, Haiyan Li, Cheng Cui, Chunli Song, Miao Zhang, Erdan Dong, Fei Ye, Xu Liu, Siyan Zhan and Wenjie Tan. Their work appears in journals such as Frontiers in Pharmacology, European Journal of Pharmaceutical Sciences, Clinical Pharmacokinetics, Clinical Pharmacology & Therapeutics and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.